NIAID Funding Opportunities: Universal Influenza Vaccine, Malaria Vaccine and Monoclonal Antibody, and Mouse Models of Human Immunity

National Institute of Allergy and Infectious Diseases sent this bulletin at 11/21/2024 01:20 PM EST

Having trouble viewing this email? View it as a Web page.

Funding Opportunities

NOT-AI-24-081: Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine
NOT-AI-24-072: Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery
NOT-AI-24-078: Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity

Find more NIAID Opportunities and Announcements.

You can follow us on X, formerly known as Twitter: @NIAIDNews

National Institute of Allergy and Infectious Diseases | National Institutes of Health

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period.

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).